83 related articles for article (PubMed ID: 16245320)
1. Binding energy analysis for wild-type and Y181C mutant HIV-1 RT/8-Cl TIBO complex structures: quantum chemical calculations based on the ONIOM method.
Saen-oon S; Kuno M; Hannongbua S
Proteins; 2005 Dec; 61(4):859-69. PubMed ID: 16245320
[TBL] [Abstract][Full Text] [Related]
2. Bridge water mediates nevirapine binding to wild type and Y181C HIV-1 reverse transcriptase--evidence from molecular dynamics simulations and MM-PBSA calculations.
Treesuwan W; Hannongbua S
J Mol Graph Model; 2009; 27(8):921-9. PubMed ID: 19414275
[TBL] [Abstract][Full Text] [Related]
3. A study of the binding energies of efavirenz to wild-type and K103N/Y181C HIV-1 reverse transcriptase based on the ONIOM method.
Srivab P; Hannongbua S
ChemMedChem; 2008 May; 3(5):803-11. PubMed ID: 18338369
[TBL] [Abstract][Full Text] [Related]
4. Investigation on an orientation and interaction energy of the water molecule in the HIV-1 reverse transcriptase active site by quantum chemical calculations.
Kuno M; Palangsuntikul R; Hannongbua S
J Chem Inf Comput Sci; 2003; 43(5):1584-90. PubMed ID: 14502493
[TBL] [Abstract][Full Text] [Related]
5. Molecular modeling studies of HIV-1 reverse transcriptase nonnucleoside inhibitors: total energy of complexation as a predictor of drug placement and activity.
Kroeger Smith MB; Rouzer CA; Taneyhill LA; Smith NA; Hughes SH; Boyer PL; Janssen PA; Moereels H; Koymans L; Arnold E
Protein Sci; 1995 Oct; 4(10):2203-22. PubMed ID: 8535257
[TBL] [Abstract][Full Text] [Related]
6. Structural and energetic characterization of nucleic acid-binding to the fingers domain of Moloney murine leukemia virus reverse transcriptase.
Crowther RL; Remeta DP; Minetti CA; Das D; Montano SP; Georgiadis MM
Proteins; 2004 Oct; 57(1):15-26. PubMed ID: 15326591
[TBL] [Abstract][Full Text] [Related]
7. Effect of a bound non-nucleoside RT inhibitor on the dynamics of wild-type and mutant HIV-1 reverse transcriptase.
Zhou Z; Madrid M; Evanseck JD; Madura JD
J Am Chem Soc; 2005 Dec; 127(49):17253-60. PubMed ID: 16332074
[TBL] [Abstract][Full Text] [Related]
8. Quantum study of mutational effect in binding of efavirenz to HIV-1 RT.
Mei Y; He X; Xiang Y; Zhang DW; Zhang JZ
Proteins; 2005 May; 59(3):489-95. PubMed ID: 15789428
[TBL] [Abstract][Full Text] [Related]
9. Computational study of the interaction between TIBO inhibitors and Y181 (C181), K101, and Y188 amino acids.
Freitas RF; Galembeck SE
J Phys Chem B; 2006 Oct; 110(42):21287-98. PubMed ID: 17048958
[TBL] [Abstract][Full Text] [Related]
10. Prediction of the binding free energies of new TIBO-like HIV-1 reverse transcriptase inhibitors using a combination of PROFEC, PB/SA, CMC/MD, and free energy calculations.
Eriksson MA; Pitera J; Kollman PA
J Med Chem; 1999 Mar; 42(5):868-81. PubMed ID: 10072684
[TBL] [Abstract][Full Text] [Related]
11. Active site dynamics and combined quantum mechanics/molecular mechanics (QM/MM) modelling of a HIV-1 reverse transcriptase/DNA/dTTP complex.
Rungrotmongkol T; Mulholland AJ; Hannongbua S
J Mol Graph Model; 2007 Jul; 26(1):1-13. PubMed ID: 17046299
[TBL] [Abstract][Full Text] [Related]
12. Electronic structure, binding energy, and solvation structure of the streptavidin-biotin supramolecular complex: ONIOM and 3D-RISM study.
Li Q; Gusarov S; Evoy S; Kovalenko A
J Phys Chem B; 2009 Jul; 113(29):9958-67. PubMed ID: 19545155
[TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics-solvated interaction energy studies of protein-protein interactions: the MP1-p14 scaffolding complex.
Cui Q; Sulea T; Schrag JD; Munger C; Hung MN; Naïm M; Cygler M; Purisima EO
J Mol Biol; 2008 Jun; 379(4):787-802. PubMed ID: 18479705
[TBL] [Abstract][Full Text] [Related]
14. The structure of HIV-1 reverse transcriptase complexed with 9-chloro-TIBO: lessons for inhibitor design.
Ren J; Esnouf R; Hopkins A; Ross C; Jones Y; Stammers D; Stuart D
Structure; 1995 Sep; 3(9):915-26. PubMed ID: 8535785
[TBL] [Abstract][Full Text] [Related]
15. Inhibition activities of catechol diether based non-nucleoside inhibitors against the HIV reverse transcriptase variants: Insights from molecular docking and ONIOM calculations.
Samanta PN; Das KK
J Mol Graph Model; 2017 Aug; 75():294-305. PubMed ID: 28623781
[TBL] [Abstract][Full Text] [Related]
16. Insight into analysis of interactions of GW9508 to wild-type and H86F and H137F GPR40: a combined QM/MM study and pharmacophore modeling.
Lu SY; Jiang YJ; Zou JW; Luo HB; Wu TX
J Mol Graph Model; 2011 Apr; 29(6):818-25. PubMed ID: 21334233
[TBL] [Abstract][Full Text] [Related]
17. Chimeric thermostable DNA polymerases with reverse transcriptase and attenuated 3'-5' exonuclease activity.
Schönbrunner NJ; Fiss EH; Budker O; Stoffel S; Sigua CL; Gelfand DH; Myers TW
Biochemistry; 2006 Oct; 45(42):12786-95. PubMed ID: 17042497
[TBL] [Abstract][Full Text] [Related]
18. Monte Carlo calculations on HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor 8-Cl TIBO: contribution of the L100I and Y181C variants to protein stability and biological activity.
Smith MB; Lamb ML; Tirado-Rives J; Jorgensen WL; Michejda CJ; Ruby SK; Smith RH
Protein Eng; 2000 Jun; 13(6):413-21. PubMed ID: 10877852
[TBL] [Abstract][Full Text] [Related]
19. Additional level of information about complex interaction between non-nucleoside inhibitor and HIV-1 reverse transcriptase using biosensor-based thermodynamic analysis.
Geitmann M; Danielson UH
Bioorg Med Chem; 2007 Dec; 15(23):7344-54. PubMed ID: 17870544
[TBL] [Abstract][Full Text] [Related]
20. Structure and adsorption of a basic probe molecule on H-ZSM-5 nanostructured zeolite: an embedded ONIOM study.
Lomratsiri J; Probst M; Limtrakul J
J Mol Graph Model; 2006 Oct; 25(2):219-25. PubMed ID: 16431144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
